IAC Express 2011 |
|
Issue number 945: August 8, 2011 |
|
|
| Please click here to subscribe to IAC Express
as well as other FREE IAC periodicals. |
|
Contents
of this Issue
Select a title to jump to the article. |
- New: July
issue of Vaccinate Adults is now online
- Reminder:
July issue of Needle Tips available online
- MMWR
publishes CDC's updated recommendations for use of meningococcal conjugate
vaccine
- IAC's
Video of the Week features IAC Executive Director Dr. Deborah L. Wexler
speaking about back-to-school vaccination
- Spotlight
on immunize.org: A to Z Index
- FDA and
manufacturers provide resources in response to advisory committees' new
recommendations on safe use of acetaminophen in children
- Journal
of Infectious Diseases publishes CDC's special supplement on global
progress toward measles eradication
- July
issue of CDC's Immunization Works newsletter now available
- IAC's
popular laminated versions of the 2011 U.S. immunization schedules are
available. Order a supply for your workplace today!
-
Award-winning DVD! "Immunization Techniques: Best Practices with Infants,
Children, and Adults"--from the California Department of Public Health,
Immunization Branch
-
Landscape analysis investigates potential drivers of strong routine
immunization system performance in Africa
|
| |
| Abbreviations |
|
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
| |
|
Issue 945: August 8, 2011 |
|
|
|
1. |
New: July issue of Vaccinate Adults is now online
The July issue of Vaccinate Adults is now online
for
downloading at http://www.immunize.org/va/va32.pdf
This issue is primarily devoted to giving healthcare
professionals information they need to respond to measles
outbreaks across the U.S. The issue also brings readers some
of IAC's most popular resources: the latest version of the
summary of immunization recommendations for adults; links to
10 of our standing orders for adult vaccine administration;
and much more.
It also includes the Ask the Experts column from CDC experts
Andrew T. Kroger, MD, MPH; Donna L. Weaver, RN, MN; and
William L. Atkinson, MD, MPH.
To download a PDF of the entire 16-page issue of Vaccinate
Adults, go to: http://www.immunize.org/va/va32.pdf
To access the Vaccinate Adults table of contents where you
can view and print individual sections, go to:
http://www.immunize.org/va Back issues are accessible from
this page as well.
Back to top |
| |
|
|
2. |
Reminder: July issue of Needle Tips available online
The July issue of Needle Tips is available online
for
viewing, downloading, and printing.
To download the entire issue right now, go to:
http://www.immunize.org/nslt.d/n49/n49.pdf
To view the table of contents, use a magazine viewer, or
access back issues, go to: http://www.immunize.org/nt
Back to top |
| |
|
|
3. |
MMWR publishes CDC's updated recommendations for use of meningococcal
conjugate vaccine
The August 5 issue of MMWR includes an article
titled
"Licensure of a Meningococcal Conjugate Vaccine for Children
Aged 2 Through 10 Years and Updated Booster Dose Guidance
for Adolescents and Other Persons at Increased Risk for
Meningococcal Disease--Advisory Committee on Immunization
Practices (ACIP), 2011." Portions of the article are
reprinted below.
In January 2011, the Food and Drug Administration lowered
the approval age range for use of MenACWY-CRM (Menveo,
Novartis Vaccines and Diagnostics), a quadrivalent
meningococcal conjugate vaccine, to include persons aged 2
through 55 years. One other quadrivalent meningococcal
conjugate vaccine, MenACWY-D (Menactra, sanofi pasteur), is
licensed in the United States for prevention of
meningococcal disease caused by serogroups A, C, Y, and W-135 among persons aged 2 through 55 years; MenACWY-D also is
licensed as a 2-dose series for children aged 9 through 23
months. The Advisory Committee on Immunization Practices
(ACIP) recommends that persons aged 2 through 55 years at
increased risk for meningococcal disease and all adolescents
aged 11 through 18 years be immunized with meningococcal
conjugate vaccine. ACIP further recommended, in January
2011, that all adolescents receive a booster dose of
quadrivalent meningococcal conjugate vaccine at age 16
years. This report summarizes data supporting the extended
age indication for MenACWY-CRM and the interchangeability of
the two licensed meningococcal conjugate vaccines. . . .
USE OF MENINGOCOCCAL CONJUGATE VACCINE IN CHILDREN AGED 2
THROUGH 10 YEARS
ACIP recommends vaccination with meningococcal conjugate
vaccine for children aged 2 through 10 years at increased
risk for meningococcal disease. A 2-dose primary series is
recommended for children with terminal complement
deficiencies (e.g., C5-C9, properdin, factor H, or factor D
deficiencies) or anatomic or functional asplenia. A single
primary dose is recommended for children with increased risk
for disease because they are travelers to or residents of
countries in which meningococcal disease is hyperendemic or
epidemic (e.g., the meningitis belt of sub-Saharan Africa).
Either meningococcal conjugate vaccine can be used in
children aged 2 through 10 years and both are preferred over
quadrivalent meningococcal polysaccharide vaccine. This
recommendation supersedes the previous recommendation that
children aged 2 through 10 years should receive only
MenACWY-D when meningococcal vaccination is indicated.
Children aged 2 through 10 years with no increased risk for
meningococcal disease are not recommended to receive any
meningococcal vaccine.
INTERCHANGEABILITY OF MenACWY-CRM AND MenACWY-D
In January 2011, ACIP recommended a single booster dose of
meningococcal conjugate vaccine for adolescents who received
a previous dose before age 16 years. For persons aged 2
through 55 years at increased risk for meningococcal disease
(i.e., persons with asplenia or terminal complement
deficiencies, or laboratory workers who work with Neisseria
meningitidis), a booster dose is recommended if they remain
at increased risk. . . .
Healthcare providers should use every opportunity to provide
the booster dose when indicated, regardless of the vaccine
brand used for the previous dose or doses.
To access the ready-to-print (PDF) version of the article,
go to pages 1018-1019 of this document:
http://www.cdc.gov/mmwr/pdf/wk/mm6030.pdf
To access the article in web-text (HTML) format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6030a3.htm
Back to top |
| |
|
|
4. |
IAC's Video of the Week features IAC Executive Director Dr. Deborah L. Wexler
speaking about back-to-school vaccination
IAC encourages IAC Express readers to watch a
4-minute video
of IAC Executive Director Deborah L. Wexler, MD, being
interviewed about back-to-school vaccination. The interview
recently aired on KARE 11 TV, NBC's affiliate in
Minneapolis-St. Paul.
The video will be available on the home page of IAC's
website through August 15. To access it, go to:
http://www.immunize.org and click on the image under the
words Video of the Week.
Remember to bookmark IAC's home page to view a new video
every Monday.
To access the archives of IAC's Videos of the Week, go to:
http://www.immunize.org/votw
Back to top |
| |
|
|
5. |
Spotlight on immunize.org: A to Z Index
Looking for quick access to IAC's web sections
and
resources? Look no further. IAC's A-to-Z Index provides an
alphabetical listing of links to the majority of web
sections and resources on immunize.org. At the very top of
each page, you'll find the link to this handy index.
To access the A-Z Index, please visit http://www.immunize.org/a-z
Back to top |
| |
|
|
6. |
FDA and manufacturers provide resources in response to advisory committees'
new recommendations on safe use of acetaminophen in children
On May 17-18, FDA's Nonprescription Drugs
Advisory Committee
and Pediatric Advisory Committee met jointly to discuss how
to reduce medication errors and make children's over-the-counter (OTC) medicines that contain acetaminophen safer to
use. According to an article titled "Reducing Fever in
Children: Safe Use of Acetaminophen," which was published in
FDA's consumer publication Consumer Health Information, the
committees recommended the following:
-
That liquid, chewable, and tablet forms be made in just
one strength. Currently, there are seven strengths available
for these forms combined.
-
That dosing instructions to reduce fever be developed for
children as young as 6 months. Current instructions apply to
children ages 2 to 12 years and [instructions] for those
under 2, only state "consult a doctor."
-
That dosing instructions be based on weight, not just age.
-
[That standards be set] for dosing devices, such as spoons
and cups, for children's medicines. Currently, some use
milliliters (mL) while others use cubic centimeters (cc) or teaspoons (tsp).
To access the complete FDA article, go to:
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm263989.htm
In response to the committees' recommendations, OTC drug
manufacturers have made resources available for healthcare
professionals. Following are titles and links to some
resources.
The following four links are from McNeil Consumer Healthcare
(maker of Tylenol)
(1) Q&As:
http://www.tylenolprofessional.com/faqs_pediatric-product-update.html
(2) Infants' Acetaminophen Dosing Change:
http://www.tylenolprofessional.com/assets/PED_071_PedDosing_PatEd_21.pdf
(3) Children's Tylenol Dosing Chart:
http://www.tylenolprofessional.com/products/childrens-suspension-liquid.html
In the right column of the page, click on the word Dosing,and you will be taken to the chart.
(4) Letter to Healthcare Professionals--Important Update on
Dosing and Concentration Changes for OTC Infants'
Acetaminophen:
http://www.tylenolprofessional.com/letter_important_update_dosing_changes_for_otc_infants.html
The following link is to a briefing book submitted to FDA by
the Consumer Healthcare Products Association, an industry
association of manufacturers and distributors of OTC
medicines and nutritional supplements:
http://www.chpa-info.org/media/resources/r_7210.pdf#search=%22Briefing%22
Back to top |
| |
|
|
7. |
Journal of Infectious Diseases publishes CDC's special supplement on global
progress toward measles eradication
[The following is cross posted from the July 2011
issue of
CDC's Immunization Works electronic newsletter.]
JOURNAL OF INFECTIOUS DISEASES--MEASLES SUPPLEMENT: CDC
published a special supplement on global progress toward measles eradication and prevention of rubella and congenital
rubella syndrome in the July 1st issue of the Journal of
Infectious Diseases (JID). The supplement is a comprehensive
review of the global efforts to eradicate measles and
reaffirms a WHO Advisory Group conclusion that "measles can
and should be eradicated." . . .
Abstracts of the articles are available online at
http://jid.oxfordjournals.org/content/204/suppl_1.toc or
call (404) 639-3286 to receive printed copies.
[IAC Express editor's note: IAC encourages readers who are
not subscribers to JID, and who are interested in reading
the full text of one or more articles in the supplement, to
contact their local medical library.]
To access the July 2011 issue of CDC's Immunization Works
electronic newsletter, go to
http://www.cdc.gov/vaccines/news/newsltrs/imwrks/2011/201107.htm
Back to top |
| |
|
|
8. |
July
issue of CDC's Immunization Works newsletter now available
CDC recently released the July issue of its
monthly
newsletter Immunization Works and posted it on the website
of the National Center for Immunization and Respiratory
Diseases (NCIRD). The newsletter offers the immunization
community information about current topics. The information
is in the public domain and can be reproduced and circulated
widely.
Most articles in the July Immunization Works newsletter have
been covered in this or previous issues of IAC Express.
To access the July issue, go to:
http://www.cdc.gov/vaccines/news/newsltrs/imwrks/2011/201107.htm
Back to top |
| |
|
|
9. |
IAC's popular laminated versions of the 2011 U.S. immunization schedules are
available. Order a supply for your workplace today!
IAC's laminated versions of the 2011 U.S.
child/teen and
adult immunization schedules are covered with a tough,
washable coating that lets them stand up to a year's worth
of use in every area of your workplace where immunizations
are given. Each has six pages (i.e., three double-sided
pages) and is folded to measure 8.5" by 11".
Laminated schedules are printed in color for easy reading,
come complete with essential tables and footnotes, and
include contraindications and precautions--a feature that
will help you make an on-the-spot determination about the
safety of vaccinating patients of any age.
PRICING
1-4 copies: $7.50 each
5-19 copies: $5.50 each
20-99 copies: $4.50 each
To view images of the laminated schedules, or to order
online or download an order form, go to:
http://www.immunize.org/shop/laminated-schedules.asp
For quotes on customizing or placing orders in excess of 999
schedules, call (651) 647-9009 or email admininfo@immunize.org
To learn about other essential immunization resources
available for purchase from IAC, go to: http://www.immunize.org/shop
Back to top |
| |
|
|
10. |
Award-winning DVD! "Immunization Techniques: Best Practices with Infants,
Children, and Adults"--from the California Department of Public Health,
Immunization Branch
The California Department of Public Health (CDPH),
Immunization Branch, has updated its award-winning training
video, "Immunization Techniques: Best Practices with
Infants, Children, and Adults." The 25-minute program can be
used to train new employees and to refresh the skills of
experienced staff. The video demonstrates the skills and
techniques needed to administer vaccines to patients of all
ages.
Prices start at $17 each for 1-9 copies and are greatly
reduced for large orders, dropping to $3 each for 1,000-1,499 copies.
To learn more about the DVD, and find out how to order it,
go to: http://www.immunize.org/dvd
For quotes on larger quantities, call (651) 647-9009 or
email admininfo@immunize.org
The Immunization Action Coalition is the only nationwide
vendor of the DVD.
Note for healthcare settings located in California: Contact
your local health department immunization program for a free
copy.
Back to top |
| |
|
|
11. |
Landscape analysis investigates potential drivers of strong routine
immunization system performance in Africa
The Africa Routine Immunization System Essentials
(ARISE)
project, managed by John Snow, Inc. with funding from the
Bill & Melinda Gates Foundation, documents successful
interventions that drive strong routine immunization system
performance in Africa and analyzes their potential for
diffusion throughout the region. ARISE translates these
tested solutions into focused options for supporting routine
immunization at the global, regional, national, and sub-national levels.
As a first step, ARISE conducted a landscape analysis to
identify potential drivers of strong routine immunization
performance in Africa. A report of the landscape analysis,
titled "Landscape Analysis Synopsis: An Initial
Investigation of the Drivers of Routine Immunization System
Performance in Africa" is available at
http://www.jsi.com/JSIInternet/Resources/Publications/childsurvival.cfm#immunization
According to its website, John Snow, Inc., and its nonprofit
affiliate JSI Research & Training Institute, Inc., are
public health research and consulting firms dedicated to
improving the health of individuals and communities
throughout the world.
Back to top |
| |
|
|
